Efficacy of gemcetabine and LY294002 on the growth of human pancreatic cancer cell lines BxPc-3 and MiaPaCa-2
10.3760cma.j.issn.1009-9921.2012.06.009
- VernacularTitle:吉西他滨与LY294002对人类胰腺癌细胞BxPc-3及MiaPaCa-2的影响
- Author:
Fei WANG
;
Yiqin ZHANG
;
Guanghai DAI
- Publication Type:Journal Article
- Keywords:
Pancreatic cancer;
Gemcetabine;
LY294002;
Apoptosis
- From:
Cancer Research and Clinic
2012;24(6):389-391,394
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of gemcetabine and LY294002 monotherapy or combination on the proliferation and poptosis of pancreatic cancer cell lines BxPc-3 and MiaPaCa-2.Methods Cell proliferation and poptosis were detected by MTT and Annexin V-FTTC,respectively.Results Both gemcetabine and LY294002 could inhabit the proliferation of the two cell lines.Their inhibitory effects were increased accompanied with increased drug concentrations and the cell survival rates was negatively correlated with logarithmic of the drug concentrations (r＜-0.95,P＜0.01).The inhibitory effects of gemcetabine and LY294002 to the BxPc-3 proliferation were significantly stronger than to the MiaPaCa-2(P＜0.05).For BxPc-3 and MiaPaCa-2,the IC50 of gemcetabine were(10.07±1.83),(36.45±2.71)μmol/L(P＜0.05),and the IC50 of LY294002 were(7.84±1.48),(17.89±1.98)μmol/L(P＜0.05),respectively.Gemcetabine and LY294002 could induce cell apoptosis(P＜0.01).Though both the concurrent or consecutive use of these two drugs could promote cell apoptosis,the effect of the concurrent group was significantly stronger(P＜0.05).The order of these two drugs in the concurrent group had no significant influence on their effects(P＞0.05).Conclusion Both gemcetabine and LY294002 could inhibit the proliferation of pancreatic cancer cell lines.Their concurrent application shows a significant inhibitory effect on the cell apoptosis.
